生物防御市场：按产品、最终用户和地区划分

2025 年全球生物防御市场规模估计为 177.5 亿美元，预计到 2032 年将达到 294.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.5%。

数字。生物防御市场占有率（%）（按地区，2025 年）

生物防御涉及保护公民免受细菌、病毒、毒素和其他可用作反人类武器的生物药品等生物威胁。生物技术的进步增加了全球生物恐怖主义的威胁，也增加了对强大的生物防御系统的需求。生物恐怖主义是故意使用病原微生物或毒素造成人类、动物或植物死亡或生病。随着生物武器变得越来越复杂和易于获取，各国正大力投入研究、检测、预防和应对措施，以保护公众健康。全球生物防御市场为威胁监控、医疗对策的储存和交付以及生物危害检测和应对培训提供了创新的解决方案。

市场动态

政府和非政府组织为提高生物威胁防范能力而不断增加的投资推动了生物防御市场的发展。全球范围内生物恐怖主义案例的不断增加以及由于科学进步而导致的生物武器的日益普及也迫使各国加强其生物防御基础设施和库存。然而，生物防御系统的研究、开发和采购高成本，限制了其更广泛的应用。此外，缺乏标准化的准则和法规也为市场相关人员带来了挑战。市场在新型病原体检测技术和治疗方法的研发力度不断加大中看到了机会。价格实惠的便携式检测器的开发有可能在全部区域广泛应用。

研究的主要特点

• 本研究报告对全球生物防御市场进行了详细分析，提供了预测期（2025-2032，假设 2024 年为基准年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球生物防御市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过全球生物防御市场分析中使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第 4 章。全球生物防御市场-冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球生物防御市场（按产品划分）（十亿美元）

• 介绍
• 炭疽菌
• 天花
• 肉毒桿菌中毒
• 辐射
• 其他的

6. 2020 年至 2032 年全球生物防御市场（以最终用户划分）（十亿美元）

• 介绍
• 医院
• 门诊治疗中心
• 研究所
• 军队
• 其他的

7. 2020 年至 2032 年全球生物防御市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• 公司简介
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

第 9 章分析师建议

• 兴衰
• 一致的机会地图

第十章参考文献与调查方法

• 参考
• 调查方法

Global Biodefense Market is estimated to be valued at USD 17.75 Bn in 2025 and is expected to reach USD 29.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Biodefense Market Share (%), By Region 2025

Biodefense involves protecting citizens from biological threats such as bacteria, viruses, toxins, and other biological agents that can be used as weapons against humanity. The rising threat of bioterrorism across the globe due to advancements in biotechnology has propelled the need for robust bio defense systems. Bioterrorism refers to the intentional use of pathogenic microorganisms or toxins to cause death or disease among humans, animals or plants. As bioweapons become more sophisticated and accessible, nations are investing heavily in research, detection, prevention and response measures to safeguard public health. The global bio defense market offers innovative solutions for threat surveillance, stockpiling and delivery of medical countermeasures, biohazard detection and response trainings.

Market Dynamics:

The bio defense market is driven by the increasing investments by government and non-government bodies to foster preparedness against biological threats. Escalating instances of bioterrorism globally and the growing accessibility of bioweapons through scientific advancement are also compelling nations to bolster their bio defense infrastructure and stockpiles. However, high costs associated with the research, development and procurement of bio defense systems limit wider adoption. Furthermore, lack of standardized guidelines and regulations pose challenges for market players. The market sees opportunities with growing R&D efforts for new pathogenic detection technologies and therapies. The development of affordable and portable bio detectors holds potential for broader usage across high-risk areas.

Key Features of the Study:

• This report provides an in-depth analysis of the global biodefense market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biodefense market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Emergent BioSolutions, SIGA Technologies Inc., Elusys Therapeutics, Inc., Altimmune, DynPort Vaccine Company LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biodefense market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodefense market.

Detailed Segmentation-

• By Product
  • Anthrax
  • Small Pox
  • Botulism
  • Radiation
  • Others
• By End User
  • Hospitals
  • Ambulatory Care Centers
  • Research Organizations
  • Military
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation.
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Biodefense Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Biodefense Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Anthrax
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Small Pox
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Botulism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biodefense Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Military
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biodefense Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • XOMA corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Altimmune Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emergent Biosolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynavax Technologies Corporation.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SIGA Technologies.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elusys Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ichor Medical Systems.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynport Vaccine Company.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland Biolabs.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bavarian Nordic.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ology Bioservices.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alnylam Pharmaceuticals Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chimerix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland BioLabs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pluristem Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact